Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

All Bets Are off for Speculative Long-Shot Ocugen Stock

By Thomas Niel, InvestorPlace Contributor

With this in mind, the best bet is to avoid Ocugen stock. Shares could skyrocket if OCU300 shows positive top-line results. Conversely, shares could fall to new lows if results do not match expectations. It may be temping to place a buy order and hope for the best. But, long-term, investing success requires discretion, not speculation. Seek more solid opportunities elsewhere, and put Ocugen on hold for now.

With NVDA Stock Topping Out, It May Be Time to Sell

By Thomas Niel, InvestorPlace Contributor

Although NVDA stock has moved significantly higher from its lows, competitive risks and a rich premium should worry shareholders.

While Risks Remain, VBI Vaccines Stock Is a Buy at Today’s Prices

By Thomas Niel, InvestorPlace Contributor

Sci-B-Vac's success will make or break VBIV stock. But the shares' recent pullback may have created a great buying opportunity.

Adobe Stock Could Head Higher, but Tread Carefully

By Thomas Niel, InvestorPlace Contributor

There's no doubt Adobe is a strong business. But is ADBE stock a strong buy at today's prices? The rally could continue, but be careful.

Shopify Stock May Finally Cool Down After Its Epic Rally

By Thomas Niel, InvestorPlace Contributor

If you bought Shopify stock at lower levels, why let it ride as the runaway bull market fades? You may kick yourself if Q4 results beat expectations. But if results fail to live up, shares could just as easily fall further.

3 Healthcare Stocks to Buy This Week Ahead of Earnings

By Thomas Niel, InvestorPlace Contributor

The markets may be taking a dip, but these three healthcare stocks could be your portfolio's prescription as earnings season is in full swing.

A Short Squeeze Could Move Aurora Stock, but Don’t Bet on It

By Thomas Niel, InvestorPlace Contributor

Paying $2/share for Aurora stock today looks foolish. The odds of shares heading to $1 seem greater than the stock rebounding to $5 or even $10/share. Yet, I wouldn't count out a short squeeze. The company is estimated to release earnings in a few weeks. If Aurora can show improved results, shares could skyrocket as shorts cover positions.Bottom line: stay away from Aurora stock. Whether on the long side or short side.

How Political Changes Could Impact Walmart Stock

By Thomas Niel, InvestorPlace Contributor

With a high forward P/E, Walmart stock is priced for perfection. Watch out for political changes this year, which may impact shares.

Despite Recent Moves, the Odds Are Against Fuel Cell Energy Stock

By Thomas Niel, InvestorPlace Contributor

Add in a variety of negative factors, and shares could easily tumble back below $1/share. Does that mean go short FCEL? Watch out in this market! As seen with stocks like Nio, bad fundamentals does not mean shares can't rally higher on speculation alone. The smart move? Don't try to play FCEL stock. Look for less volatile opportunities elsewhere.

Sell Canopy Growth Shares Now Before CGC Loses Its Spark

By Thomas Niel, InvestorPlace Contributor

Investors may not offer CGC stock a Constellation premium much longer, which means shares could head much lower.

Load More